© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 23, 2009-2014,
December 1, 1999
© 1999 Oxford University Press
REPORTS |
Environmental Tobacco Smoke, Genetic Susceptibility, and Risk of Lung Cancer in Never-Smoking Women
Affiliations of authors: W. P. Bennett, B. Blomeke, J. A. Welsh, E. D. Bowman, M. A. Khan, C. C. Harris (Laboratory of Human Carcinogenesis, Division of Basic Sciences), M. C. R. Alavanja (Radiation Epidemiology Branch, Division of Cancer Epidemiology), National Cancer Institute, Bethesda, MD; K. H. Vähäkangas, K. Castrén, Department of Pharmacology and Toxicology, University of Oulu, Finland; D. B. Flieder, Department of Pathology, Cornell University Medical Center, New York, NY.
Correspondence to: Curtis C. Harris, M.D., National Institutes of Health, Bldg. 37, Rm. 2C01, Bethesda, MD 20892-4255 (e-mail curtis_harris{at}nih.gov).
BACKGROUND: Exposure to environmental tobacco smoke (ETS) is considered to be a major lung cancer risk factor for never smokers. We investigated the hypothesis that never-smoking women who are exposed to ETS and develop lung cancer are a genetically susceptible population. METHODS: Archival tumor tissues were analyzed from 106 never-smoking women enrolled in a case-control study of ETS (and other personal and environmental factors) and lung cancer risk. We analyzed germline polymorphisms in genes that have been associated with cancer susceptibility and whose products activate (cytochrome P450 1A1 [CYP1A1]) and detoxify (glutathione S-transferases M1 [GSTM1] and T1 [GSTT1]) chemical carcinogens found in tobacco smoke. RESULTS: When compared with never smokers who had no ETS exposure and developed lung cancer (n = 55), never smokers with exposure to ETS who developed lung cancer (n = 51) were more likely to be deficient in GSTM1 activity (i.e., were GSTM1 null) because of a genetic polymorphism in the GSTM1 gene (odds ratio = 2.6; 95% confidence interval = 1.1-6.1). A statistically significant rising trend in risk occurred with increasing ETS exposure (two-sided P = .02), reaching a more than sixfold excess risk in those exposed to 55 pack-years of ETS (ETS pack-year = ETS produced by an active smoker, within a confined space such as a room, who smokes one pack of cigarettes a day for a year). No evidence was found of associations between GSTT1 deficiency or the CYP1A1 valine variant and lung cancer risk due to ETS exposure. CONCLUSIONS: A common genetic polymorphism divides the population of never smokers into two groups of approximately equal size, one (homozygous carriers of the GSTM1 null allele) that has a statistically significant greater risk of lung cancer from ETS than the other (heterozygous or homozygous carriers of the wild-type GSTM1 allele).
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Taylor, F. Najafi, and A. Dobson Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent Int. J. Epidemiol., October 1, 2007; 36(5): 1048 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Subramanian and R. Govindan Lung Cancer in Never Smokers: A Review J. Clin. Oncol., February 10, 2007; 25(5): 561 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Shepard, J. F. Amatruda, D. Finkelstein, J. Ziai, K. R. Finley, H. M. Stern, K. Chiang, C. Hersey, B. Barut, J. L. Freeman, et al. A mutation in separase causes genome instability and increased susceptibility to epithelial cancer Genes & Dev., January 1, 2007; 21(1): 55 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Thomas, L. A. Doyle, and M. J. Edelman Lung Cancer in Women: Emerging Differences in Epidemiology, Biology, and Therapy Chest, July 1, 2005; 128(1): 370 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.L. Cote, S.L.R. Kardia, A.S. Wenzlaff, S.J. Land, and A.G. Schwartz Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study Carcinogenesis, April 1, 2005; 26(4): 811 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Vineis, L Airoldi, F Veglia, L Olgiati, R Pastorelli, H Autrup, A Dunning, S Garte, E Gormally, P Hainaut, et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study BMJ, February 5, 2005; 330(7486): 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Georgiadis, J. Topinka, D. Vlachodimitropoulos, M. Stoikidou, M. Gioka, G. Stephanou, H. Autrup, N. A. Demopoulos, K. Katsouyanni, R. Sram, et al. Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations Carcinogenesis, January 1, 2005; 26(1): 93 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Yang, W.R. Bamlet, J.O. Ebbert, W.R. Taylor, and M. de Andrade Glutathione pathway genes and lung cancer risk in young and old populations Carcinogenesis, October 1, 2004; 25(10): 1935 - 1944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M Gatto, U. B Campbell, A. G Rundle, and H. Ahsan Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias Int. J. Epidemiol., October 1, 2004; 33(5): 1014 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Hofseth, A. I. Robles, Q. Yang, X. W. Wang, S. P. Hussain, and C. Harris p53: At the Crossroads of Molecular Carcinogenesis and Molecular Epidemiology Chest, May 1, 2004; 125(5_suppl): 83S - 85S. [Full Text] [PDF]
|
|
|
|
|
|
G. Davey Smith Effect of passive smoking on health BMJ, May 15, 2003; 326(7398): 1048 - 1049. [Full Text] [PDF]
|
|
|
|
|
|
A. Besaratinia, L.M. Maas, E.M.C. Brouwer, E.J.C. Moonen, T.M.C.M. De Kok, G.J. Wesseling, S. Loft, J.C.S. Kleinjans, and F.J. Van Schooten A molecular dosimetry approach to assess human exposure to environmental tobacco smoke in pubs Carcinogenesis, July 1, 2002; 23(7): 1171 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Stabile, A. L. G. Davis, C. T. Gubish, T. M. Hopkins, J. D. Luketich, N. Christie, S. Finkelstein, and J. M. Siegfried Human Non-Small Cell Lung Tumors and Cells Derived from Normal Lung Express Both Estrogen Receptor {alpha} and {beta} and Show Biological Responses to Estrogen Cancer Res., April 1, 2002; 62(7): 2141 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Brennan Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis, March 1, 2002; 23(3): 381 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Bogen and H. Witschi Lung tumors in A/J mice exposed to environmental tobacco smoke: estimated potency and implied human risk Carcinogenesis, March 1, 2002; 23(3): 511 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Albert, D. Ratnasinghe, J. Tangrea, and S. Wacholder Limitations of the Case-only Design for Identifying Gene-Environment Interactions Am. J. Epidemiol., October 15, 2001; 154(8): 687 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. B. J. Smith, P. A. Harper, J. M. Y. Wong, M. S. M. Lam, K. R. Reid, D. Petsikas, and T. E. Massey Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities: Impact of Smoking Status and CYP1A1, Aryl Hydrocarbon Receptor, and Glutathione S-Transferase M1 Genetic Polymorphisms Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 839 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Vahakangas, W. P. Bennett, K. Castren, J. A. Welsh, M. A. Khan, B. Blomeke, M. C. R. Alavanja, and C. C. Harris p53 and K-ras Mutations in Lung Cancers from Former and Never-Smoking Women Cancer Res., June 1, 2001; 61(11): 4350 - 4356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Anderson, S. G. Carmella, M. Ye, R. L. Bliss, C. Le, L. Murphy, and S. S. Hecht Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Women Exposed to Environmental Tobacco Smoke J Natl Cancer Inst, March 7, 2001; 93(5): 378 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Malats, A.-M. Camus-Radon, F. Nyberg, W. Ahrens, V. Constantinescu, A. Mukeria, S. Benhamou, H. Batura-Gabryel, I. Bruske-Hohlfeld, L. Simonato, et al. Lung Cancer Risk in Nonsmokers and GSTM1 and GSTT1 Genetic Polymorphism Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 827 - 833. [Abstract] [Full Text]
|
|
|
|
|
|
C. R. Weinberg and D. M. Umbach Choosing a Retrospective Design to Assess Joint Genetic and Environmental Contributions to Risk Am. J. Epidemiol., August 1, 2000; 152(3): 197 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Shields and C. C. Harris Cancer Risk and Low-Penetrance Susceptibility Genes in Gene-Environment Interactions J. Clin. Oncol., June 11, 2000; 18(11): 2309 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Tricker Re: Environmental Tobacco Smoke, Genetic Susceptibility, and Risk of Lung Cancer in Never-Smoking Women J Natl Cancer Inst, May 3, 2000; 92(9): 760 - 760. [Full Text] [PDF]
|
|
|
|
|
|
W. P. Bennett, M. C. R. Alavanja, and C. C. Harris RESPONSE: Re: Environmental Tobacco Smoke, Genetic Susceptibility, and Risk of Lung Cancer in Never-Smoking Women J Natl Cancer Inst, May 3, 2000; 92(9): 760a - 761a. [Full Text] [PDF]
|
|
|
|
 |
|
 Environmental Tobacco Smoke and Lung Cancer Journal Watch Women's Health, February 1, 2000; 2000(201): 9 - 9. [Full Text]
|
|
|
|
|
|
C. R. Weinberg and D. P. Sandler Gene-by-Environment Interaction for Passive Smoking and Glutathione S-Transferase M1? J Natl Cancer Inst, December 1, 1999; 91(23): 1985 - 1986. [Full Text] [PDF]
|
|